The Impact of Preoperative Radiochemotherapy on Survival in Advanced Esophagogastric Junction Signet Ring Cell Adenocarcinoma Sarah Bekkar, MD, Caroline Gronnier, MD, PhD, Mathieu Messager, MD, William B. Robb, MD, Guillaume Piessen, MD, PhD, Christophe Mariette, MD, PhD The Annals of Thoracic Surgery Volume 97, Issue 1, Pages 303-310 (January 2014) DOI: 10.1016/j.athoracsur.2013.09.010 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Flow chart of the study. (EGJ = esophagogastric junction; SRC = signet ring cell adenocarcinoma; UICC = Union Internationale Contre le Cancer.) The Annals of Thoracic Surgery 2014 97, 303-310DOI: (10.1016/j.athoracsur.2013.09.010) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Survival curve in the overall population (hatch marks indicate censored events). The number of subjects at risk at each interval is shown in the table at the bottom of the graph. The Annals of Thoracic Surgery 2014 97, 303-310DOI: (10.1016/j.athoracsur.2013.09.010) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Survival curves after primary surgery (group S [heavy line]; hatch marks indicate censored events in group S) and radiochemotherapy followed by surgery (group RCT [light line]; hatch marks indicate censored evens in group RCT). The number of subjects at risk at each interval is shown in the table at the bottom of the graph. The Annals of Thoracic Surgery 2014 97, 303-310DOI: (10.1016/j.athoracsur.2013.09.010) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions